Two oral presentations will highlight research related to Invea’s lead program INVA8001 and the therapeutic impact on mast cell-driven chronic inflammatory diseases
Decoding the Mechanisms that Drive Chronic Inflammation to Develop Medicines for Immune-Mediated Inflammatory Disorders
2614 Boston Post Road, Suite #33AR
Guilford, CT 06437, USA
Decoding the Mechanisms that Drive Chronic Inflammation to Develop Medicines for Immune-Mediated Inflammatory Disorders
2614 Boston Post Road Suite #33AR
Guilford, CT 06437, USA
© 2024 Invea Therapeutics, Inc. All rights reserved | Privacy Policy | Terms of Use